Dr. Robert Lehmann is a leader in his field, and his expert career includes a wide variety of publications. Click the publication type for details.
Full papers published in peer-reviewed journals
Other publications
Abstracts/Selected Papers
Book Chapters
Featured publication
Lehmann RP, and Houtman. “Visual Performance in Cataract Patients with Low Levels of Postoperative Astigmatism Full Correction Versus Spherical Equivalent Correction,” Clinical Ophthalmology, 2012; 6 (Mar): 333 – 338.
Full papers published in peer-reviewed journals
Packer M, Fry L, Lavery KT, Lehmann RP, McDonald J, Nichamin L, Bearie B, Hayashida J, Altmann GE, Khodai O. Safety and effectiveness of a glistening-free single-piece hydrophobic acrylic intraocular lens (enVista). Clinical Ophthalmology. 2013:7 1905-1912. Dovepress.
Lehmann RP, Houtman DM. Visual performance in cataract patients with low levels of postoperative astigmatism: full correction versus spherical equivalent correction. Clinical Ophthalmology. 2012 June; 333-38. Dove Medical Press Ltd.
Lane SS, Modi SS, Lehmann RP, Holland EJ. Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery. J Cataract Refract Surg. 2007;33(1):53-58. Erratum in: J Cataract Refract Surg. 2007;33(4):564. PubMed PMID: 17189793.
A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. The Epithelial Keratitis Trial. The Herpetic Eye Disease Study Group. Arch Ophthalmol. 1997 Jun;115(6):703-12. Erratum in: Arch Ophthalmol 1997 Sep;115(9):1196. PubMed PMID: 9194719.
Wilhelmus KR, Font RL, Lehmann RP, Cernoch PL. Cytomegalovirus keratitis in acquired immunodeficiency syndrome. Arch Ophthalmol. 1996;114(7):869-872. PubMed PMID: 8660174.
Robin AL, Ritch R, Shin DH, Smythe B, Mundorf T, Lehmann RP. Short-term efficacy of apraclonidine hydrochloride added to maximum-tolerated medical therapy for glaucoma. Apraclonidine Maximum-Tolerated Medical Therapy Study Group. Am J Ophthalmol.1995;120(4):423-432. PubMed PMID: 7573299.
Lehmann R, Brint S, Stewart R, White GL Jr, McCarty G, Taylor R, Disbrow D, Defaller J. Clinical comparison of Provisc and Healon in cataract surgery. J Cataract Refract Surg. 1995 Sep;21(5):543-7. PubMed PMID: 7473117.
Stewart WC, Ritch R, Shin DH, Lehmann RP, Shrader CE, van Buskirk EM. The efficacy of apraclonidine as an adjunct to timolol therapy. Apraclonidine Adjunctive Therapy Study Group. Arch Ophthalmol. 1995;113(3):287-292. Erratum in: Arch Ophthalmol. 1995;113(11):1465. Arch Ophthalmol. 1995;113(9):1112. PubMed PMID: 7887841.
Assil KK, Massry G, Lehmann R, Fox K, Stewart R. Control of ocular inflammation after cataract extraction with rimexolone 1% ophthalmic suspension. J Cataract Refract Surg. 1997;23:750-7. PubMed PMID: 9278798.
Robin AL, Ritch R, Shin D, Smythe B, Mundorf T, Lehmann RP. Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma: the Apraclonidine Maximum Tolerated Medical Therapy Study Group. Trans Am Ophthalmol Soc. 1995;93:421-438; discussion 439-441. PubMed PMID: 8719690; PubMed Central pMCID: PMC1312069.
Lehmann RP. 3M diffractive multifocal lens (letter). J Cat Refract Surg. 1991;17:241-242.
Lehmann RP. Paired comparison of contrast sensitivity in diffractive multifocal IOLs and conventional monofocal IOLs. Aust N Z J Ophthalmol. 1990;18(3):325-328. PubMed PMID: 2261181.
Lehmann R, Justice J Jr: Consideration of the cilio retinal circulation. Doc Ophthalmol Proceedings Series, 1976;40:9.
Justice J Jr, Lehmann RP. Cilioretinal arteries: a study based on review of stereo fundus photographs and fluorescein angiographic findings. Arch Ophthalmol. 1976;94(8):1355-1358. PubMed PMID: 949278.
Jackson B, Lange WR, Lehmann RP. Teenage drug abuse in middle class Milwaukee. Wis Med J. 1972;71(9):210-212. PubMed PMID: 5069121.
Lehmann RP, and Houtman. “Visual Performance in Cataract Patients with Low Levels of Postoperative Astigmatism Full Correction Versus Spherical Equivalent Correction,” Clinical Ophthalmology, 2012; 6 (Mar): 333 – 338.
Singh, Alpern, Jaffe, Lehmann RP, Lim, Reiser, Sall, Walters, and Sager. “Evaluation of Nepafenac in Prevention of Macular Edema Following Cataract Surgery in Patients with Diabetic Retinopathy,” Clinical Ophthalmology, 2012; 6: 1259-1269.
Lehmann RP. “IQ ReSTOR +3.0 D delivers improved VA at all distances,” New Paradigms and Options in Cataract & Refractive Surgery, EyeWorld 2009;14 (June): 2-3.
Lehmann RP. A new tool to analyze how much the cataract incision influences the refractive outcome. EyeWorld, 2008; 13 (June).
Lehmann RP. Roundtable: Philosophy of mixing IOLs for presbyopia correction spurs debate. Ocular Surgery News, 2006; 24 (Jan):48.
Lehmann RP. Bilateral implantation of same model presbyopia-correcting IOL is best strategy,” Differing viewpoints on implanting same or different presbyopia IOLs sow benefits of both. Ocular Surgery News, 2006; 24 (Jan): 45.
Lehmann RP. Improving cataract surgery performance: performing lens removal with the AquaLase handpiece. Ocular Surgery News, Robert Lehmann, MD. 2004; (July).
Lehmann RP. Exploring AquaLase liquefaction: technology and techniques with the newest Infiniti addition. to Cataract & Refractive Surgery Today 2004 supplement.
Lehmann RP. Blue Light Damage and the Pseudophakic Eye. Ocular Surgery News 2003 (Sept.).
Lehmann RP. Surgeon: Aqualase Lens System Improves Cataract Removal, Ocular Surgery News, 2003; (Jul).
Charters L, Lehmann RP. Modified tip design improves liquefaction procedure. Ophthalmology Times, 2003; (Feb):22.
Lehmann RP. Ocular Surgery News Europe/Asia-Pacific Edition, February 2003; (Feb): 28.
Charters L, Lehmann RP. Special Section: ASCRS cataract news – Technology reduces thermal injury in small-incision surgery. Ophthalmology Times, 2002; (Aug): 24.
Lehmann RP. AquaLase promising alternative to phacoemulsification. Ocular Surgery News, 2002;13 (Feb).
Cionni RJ, Lehmann RP. Phaco performance improves with upgrades. Ophthalmology Times, 2002; Feb: 26
Lehmann RP. AquaLase promising alternative to phacoemulsification. Ocular Surgery News, 2002; 20 (Jan).
Lehmann RP. Cataract Device May Offer Advantages Over Ultrasound. Ophthalmology Times 2001; (May): 7-9.
Lehmann RP. Biomechanics: A New Era in Intraocular Lens Technology Ocular Surgery News, 2002; (Aug): 2-15.
Lehmann RP. Antibiotic Prophylaxis In Ophthalmic Surgery. Ocular Surgery News, 1998; (May): 2-15.
Lehmann RP. Evaluating the Efficacy of Fluoroquinolones, Sixth Annual Ocular Surgery News, 1998; (Feb): 41-43.
Lehmann RP. Does the Almighty Dollar Have to Drive our Medical Decisions? Ophthalmology Management, 1997; (Oct):30.
Lehmann RP. The AcrySof advantage from A to Z: update of personal experience with over 1,000 implantations. Ocular Surgery News. 1997 (Feb): 35.
Lehmann RP. Tips on cortical cleanup. Ophthalmic Practice, December 1996.
Lehmann RP. Cortical cleaving: hydro dissection and management of the superior cortex. Ophthalmic Practice, 1996.
Lehmann RP. A legacy of enhanced performance. Phaco & Foldables, 1996; 9: 1.
Black, Brint, Fine, Gimbel, Kelman, Koch, Lehmann RP, Mackool, Milauskas, Serafano. Expanding the platform of cataract surgery into the 21st Century. Ocular Surgery News, 1996.
Arnold, Birchansky, Brint, Lane, Lehmann RP, Maxwell, Salvitti, Solomon. Small incision cataract surgery: improved materials for enhanced patient outcomes,” Ocular Surgery News. 1996.
Lehmann RP. Acrylic IOL update: using the wagon wheel. Ocular Surgery News. 1995;13:28-30.
Lehmann RP. AcrySof: personal experience with 140 implantations - Core investigator of acrylic lens lauds results, properties. Ocular Surgery News. 1995;13: 38.
Lehmann RP. Acrylic versus silicone and PMMA lenses. Phaco & Foldables. 1994; 7:7.
Lehmann RP. How to do scleral tunnel incisions with only topical anesthesia. Review of Ophthalmology, 1994;1:34-36.
Lehmann RP. New Type of Sodium Hyaluronate Studied Ophthalmology Times, 1990; 15:1, 20.
Lehmann RP. Your first phaco: selecting for success, Phaco & Foldables, 1989; 2:2.
Lehmann RP. Experience with 3M Diffractive Multifocal IOL: Follow-up on a Small Series. Implants in Ophthalmology,1989; 3:74-76.
Lehmann RP. Early Experience with Oval PMMA Indicates Advantages of Smaller Incision. Phaco & Foldables, 1989; 2: 1-3, 6.
Lehmann RP. A cut above – scleral tunnel. Review of Ophthalmology, 1987:89-91.
ASCRS/ASOA Symposium on Cataract, IOL, and Refractive Surgery
April 3-7, 2009 San Francisco, CA
Scientific paper: Comparison of visual acuity results for the AcrySof ReSTOR aspheric +3.0 D add power IOL and the AcrySof +4.0 D add power IOL
ASCRS/ASOA Symposium on Cataract, IOL, and Refractive Surgery
April 3-8, 2008 Chicago, IL
Scientific Paper: Visual outcomes after bilateral implantation of the ReSTOR IOL and the ReSTOR aspheric IOL
Scientific Poster: Clinically relevant advantages in the functional performance of the AcrySof IQ IOL
ASCRS/ASOA Symposium on Cataract, IOL, and Refractive Surgery
April 26 – May 2, 2007, San Diego, CA
Scientific Paper: Functional performance of the AcrySof IQ IOL: night driving simulation and contrast sensitivity using the FACT chart
Scientific Paper: Open-label single dose pharmacokinetic: study of Nepafenac, Amfenac, and Ketorolac in human aqueous humor
Scientific Paper: Use of different phaco tips and torsional handpiece: comparison of outcomes and efficiency
Lehmann RP. AquaLase versus Phaco. In: Boyd S., Dodick J, Freitas LL, Editors. The Highlights Collection: New Outcomes in Cataract Surgery, Chapter 7, p. 79-84. Jaypee-Highlights Medical Publishers, Panama City, Panama, 2005.
Lehmann RP, Buratto L. AquaLase Cataract Removal. In: Phacoemulsification Principles and Techniques” 2nd Edition. Chapter 31.2, p.428. Slack Incorporated 2003.
Lehmann RP. Indications for foldable IOLs. In: Solomon LD, Editor, Proceedings of the Ophthalmic Advisory Panel. pp. 77-81 Montreal : Medicöpea, 1995.
Lehmann RP. Multifocal Intraocular Lenses. In: P.S. Koch and J.A. Davison, Editors, Textbook of Advanced Phacoemulsification Techniques, pp. 345-359. Slack, Thorofare, NJ 1991.